Cytology Specimen Utilization: A Proven Approach to Genetic Sequencing - Insights
PACE / State of FL - Register now - May 21, 2025: - This webinar will explore the role of cytology specimens in molecular genetic testing, emphasizing their effectiveness in identifying biomarkers critical...
Lab Billing, Coding, and Compliance: A 2025 Overview - Insights
Register now – July 8, 2025: PACE / State of FL - This webinar will discuss a range of critical topics essential for laboratory billing, coding, and compliance. Key areas of focus will include understanding...
Multiomics: A new model for identifying biomarkers to predict severe COVID-19 outcomes - Insights
predict a more severe course of COVID-19 before the patient gets sick enough to be hospitalized. Until now, there have been no biomarkers that can reliably predict which patients are more likely to have severe...
How digital pathology provides faster answers - Insights
be retrieved and delivered. This has significantly improved patient care because pathologists can now discuss cases with clinicians and surgeons in real time....
Fergus Couch, Ph.D., co-authors new guidelines for interpreting ATM cancer gene variants - Insights
mutations in ATM have been shown to increase the risk of breast, pancreatic, and prostate cancers. Now published by the American Journal of Human Genetics and available for widespread use, Dr. Couch says...
Mayo Clinic Laboratory and Pathology Research Roundup: March 5 - Insights
comprised of missense or intronic variants, have been identified in BRCA2, the few missense variants now classified clinically as pathogenic or likely pathogenic are predominantly located in the region encoding...
Making the Promise of AI a Reality in Laboratory Medicine and Pathology - Insights
Register now – June 26, 2025 PACE / State of FLThis webinar explores how artificial intelligence (AI) and digital pathology have the potential to revolutionize the clinical laboratory landscape. These...
50th Anniversary Stories - Insights
From a small-scale enterprise with a two-man sales force and a limited testing menu, to a world-renowned reference lab with an expansive testing catalog featuring more than 3,500 assays, Mayo Clinic Laboratories has experienced significant...
Shining light on one family's struggle: Barbara, Deborah, Pamela, and Rylie - Insights
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...